| scholarly article | Q13442814 |
| P2093 | author name string | Douglas C Bauer | |
| P2860 | cites work | Clinical practice. Vitamin D insufficiency | Q37830043 |
| Calcium insufficiency and fracture risk | Q41225852 | ||
| Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EP | Q44134210 | ||
| Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). | Q51032795 | ||
| The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. | Q55063217 | ||
| Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up | Q57220169 | ||
| Do calcium plus vitamin D supplements increase cardiovascular risk? | Q58486028 | ||
| Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women | Q77916693 | ||
| Dietary calcium and magnesium intake and mortality: a prospective study of men | Q82982181 | ||
| Commentary on calcium supplements and cardiovascular events | Q83415809 | ||
| Calcium supplements and risk of myocardial infarction: an hypothesis twice tested | Q83736372 | ||
| The calcium scare--what would Austin Bradford Hill have thought? | Q84247768 | ||
| Authors' response to editorial | Q84302980 | ||
| Calcium supplements and risk of myocardial infarction: a hypothesis formulated but not yet adequately tested | Q84613792 | ||
| Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement | Q22305319 | ||
| Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force | Q22305325 | ||
| Calcium Supplementation in Clinical Practice: A Review of Forms, Doses, and Indications | Q22306250 | ||
| Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study | Q22306543 | ||
| Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis | Q24548778 | ||
| Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis | Q24600663 | ||
| Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study | Q24629648 | ||
| Calcium requirements: new estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies | Q31132467 | ||
| Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial | Q33567637 | ||
| Estimation of total usual calcium and vitamin D intakes in the United States | Q33727956 | ||
| Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events | Q34101483 | ||
| Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative | Q34131326 | ||
| Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis | Q34146697 | ||
| Why randomized controlled trials of calcium and vitamin D sometimes fail | Q34296402 | ||
| Calcium plus vitamin D supplementation and the risk of fractures | Q34495055 | ||
| Calcium/vitamin D supplementation and cardiovascular events | Q34575880 | ||
| Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. | Q34667408 | ||
| Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women | Q34738989 | ||
| Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study | Q35004604 | ||
| Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements | Q35080317 | ||
| A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men | Q35093969 | ||
| Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones | Q35373518 | ||
| The effect of vitamin D on calcium absorption in older women | Q36293583 | ||
| Calcium intake is not associated with increased coronary artery calcification: the Framingham Study | Q36398326 | ||
| Calcium fortificants: overview and strategies for improving calcium nutriture of the U.S. population | Q37012166 | ||
| Effect of calcium supplementation on hip fractures | Q37088958 | ||
| Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). | Q37395875 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone fracture | Q68833 |
| prevention | Q1717246 | ||
| P304 | page(s) | 1537-1543 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Clinical practice. Calcium supplements and fracture prevention | |
| P478 | volume | 369 |
| Q35223327 | A practical approach to osteoporosis management in the geriatric population |
| Q90259831 | Absorption Characteristics of Novel Compound Calcium Carbonate Granules: Effects of Gastric Acid Deficiency and Exogenous Weak Acids |
| Q59586911 | Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women |
| Q59586829 | Acute effects of calcium supplements on blood pressure: randomised, crossover trial in postmenopausal women |
| Q33896703 | Analysis of inorganic and organic constituents of myrrh resin by GC-MS and ICP-MS: An emphasis on medicinal assets |
| Q56888027 | Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
| Q92218757 | Associated Factors for Osteoporosis and Fracture in Chinese Elderly |
| Q47738927 | Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. |
| Q53750872 | Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial. |
| Q38358763 | Calcium and bone health--goodbye, calcium supplements? |
| Q26784337 | Calcium intake and bone mineral density: systematic review and meta-analysis |
| Q26784357 | Calcium intake and risk of fracture: systematic review |
| Q37376055 | Calcium supplementation and risk of dementia in women with cerebrovascular disease |
| Q26471306 | Calcium supplementation for weight reduction in overweight or obese people |
| Q38199624 | Calcium supplementation: is protecting against osteoporosis counter to protecting against cardiovascular disease? |
| Q34485049 | Calcium supplements: benefits and risks. |
| Q46276907 | Eggshell fractions containing different particle sized affect mineral absorption but not bone mineral retention in growing rats. |
| Q28072047 | Food fortification for bone health in adulthood: a scoping review |
| Q53435626 | Healthy Bones Study: can a prescription coupled with education improve bone health for patients receiving androgen deprivation therapy?-a before/after study. |
| Q36067391 | Is bone equally responsive to calcium and vitamin D intake from food vs. supplements? Use of (41)calcium tracer kinetic model. |
| Q38213502 | Next-generation phosphate binders: focus on iron-based binders |
| Q36890341 | Nutrition in Cardioskeletal Health. |
| Q33969649 | Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients' bone health |
| Q39255870 | Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. |
| Q43987138 | Raloxifene modulates regulators of osteoclastogenesis and angiogenesis in an oestrogen deficiency periapical lesion model |
| Q92014211 | Relative bioavailability and pharmacokinetic comparison of calcium glucoheptonate with calcium carbonate |
| Q43665136 | The calcium supplement controversy: now what? |
| Q38260474 | The cardiovascular safety aspects of calcium supplementations: where does the truth lie? A personal perspective |
| Q50905717 | Therapeutic effect of icariin combined with stem cells on postmenopausal osteoporosis in rats. |
| Q38287232 | Treatment of osteoporosis: current state of the art. |
Search more.